Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Cempra Pharmaceuticals completes its Series A round

Executive Summary

Cempra Pharmaceuticals (developing therapeutics to treat drug-resistant bacteria in the hospital and at home) has raised $22mm with its Series A venture round. Intersouth Partners and I. Wistar Morris, III (an investment banker) co-led the financing and were joined by new backer Aisling Capital.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register